Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organogenesis Holdings (ORGO) Return on Invested Capital (2017 - 2025)

Historic Return on Invested Capital for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to 0.05%.

  • Organogenesis Holdings' Return on Invested Capital fell 300.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year decrease of 300.0%. This contributed to the annual value of 0.02% for FY2024, which is 400.0% down from last year.
  • Organogenesis Holdings' Return on Invested Capital amounted to 0.05% in Q3 2025, which was down 300.0% from 0.08% recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Return on Invested Capital high stood at 0.37% for Q4 2021, and its period low was 0.1% during Q1 2025.
  • In the last 5 years, Organogenesis Holdings' Return on Invested Capital had a median value of 0.05% in 2023 and averaged 0.1%.
  • As far as peak fluctuations go, Organogenesis Holdings' Return on Invested Capital surged by 6000bps in 2021, and later plummeted by -3100bps in 2022.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Return on Invested Capital stood at 0.37% in 2021, then tumbled by -83bps to 0.06% in 2022, then tumbled by -67bps to 0.02% in 2023, then tumbled by -178bps to 0.02% in 2024, then plummeted by -226bps to 0.05% in 2025.
  • Its Return on Invested Capital was 0.05% in Q3 2025, compared to 0.08% in Q2 2025 and 0.1% in Q1 2025.